Increased exhaled 8-isoprostane in childhood asthma

P. Montuschi, L. Ghiro, V. Piovan, S. Carraro, C. Mondino, G. Ciabattoni, E. Baraldi (Rome, Chieti, Italy)

Source: Annual Congress 2002 - The role of inflammatory markers in children with asthma
Session: The role of inflammatory markers in children with asthma
Session type: Thematic Poster Session
Number: 922
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Abstract

8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate (EBC) of adults with asthma (Montuschi P. et al. Am. J. Respir. Crit. Care Med. 1999; 160:216-220). EBC is a non-invasive method of sampling secretions from the airways. The aim of this study was to quantify lung oxidative stress in children with asthma as reflected by exhaled 8-isoprostane levels. We also measured exhaled nitric oxide (NO), a marker of airway inflammation, and exhaled prostaglandin (PG) E2, since impaired production of this eicosanoid has been proposed to contribute to the pathogenesis of asthma. Twelve healthy children (3/9 M/F, age 9±]0.5 yr, FEV1 96.3±]3.5% pred) and 30 children with mild to moderate persistent asthma (20/10 M/F, age 11±]0.6 yr, FEV1 89.9±]2.6% pred) treated with inhaled corticosteroids (average dose 300 mg/day) were studied. Exhaled 8-isoprostane and PGE2 were measured by specific radioimmunossays developed in our laboratory which were validated by high performance liquid chromatography. Exhaled NO was measured with the NIOX system (Aerocrine, Sweden). Exhaled 8-isoprostane was increased in children with asthma (47.2±]2.3 pg/ml; P<0.008; 95% confidence interval [CI], 42.4-52.0) compared to healthy children (34.2±]4.5 pg/ml; 95% CI, 24.3-44.0), whereas exhaled PGE2 concentrations were similar in the two groups (51.5±]4.0 pg/ml vs 46.8±]5.3 pg/ml, respectively). Children with asthma (37.8±]6.6 ppb, P<0.04; 95% CI, 24.3-51.4) had higher exhaled NO levels than healthy children (15.2±]1.7 ppb; 95% CI, 11.4-18.9). These data indicate that lung oxidative stress is increased in children with asthma treated with inhaled steroids.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Montuschi, L. Ghiro, V. Piovan, S. Carraro, C. Mondino, G. Ciabattoni, E. Baraldi (Rome, Chieti, Italy). Increased exhaled 8-isoprostane in childhood asthma. Eur Respir J 2002; 20: Suppl. 38, 922

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased exhaled 8-isoprostane in aspirin-sensitive asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001

Exhaled 8-isoprostane as a marker of airway inflammation in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Increased exhaled leukotrienes levels in adults with chronic cough
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003

Leukotrienes and 8-isoprostane in exhaled breath condensate of children with asymptomatic steroid-naive asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Profile of prostanoids in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 400s
Year: 2003

N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 13s
Year: 2005

Leukotrienes in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 398s
Year: 2003

Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Altered exhaled biomarker profiles in children during and after rhinovirus-induced wheeze
Source: Eur Respir J 2015; 45: 440-448
Year: 2015



Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002

Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004

Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO)
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Nitrite levels in breath condensate of children with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

8-isoprostane in exhaled breath condensate (EBC) and air pollution exposure in children with wheezing
Source: Annual Congress 2012 - Indoor and outdoor air pollution
Year: 2012

The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010